Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms
University of Washington
University of Washington
M.D. Anderson Cancer Center
University of California, Irvine
Institute of Hematology & Blood Diseases Hospital, China
University of Southern California
City of Hope Medical Center
MPN Research Foundation
Brigham and Women's Hospital
Massachusetts General Hospital
University of Miami
Icahn School of Medicine at Mount Sinai
Thomas Jefferson University
UNC Lineberger Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
Barbara Ann Karmanos Cancer Institute
UNC Lineberger Comprehensive Cancer Center
City of Hope Medical Center
RWTH Aachen University
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Icahn School of Medicine at Mount Sinai